欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1413/001
药品名称
Carbidopa/Levodopa Fair-Med
活性成分
carbidopa 12.5 mg
levodopa 50.0 mg
剂型
Tablet
上市许可持有人
Fair-Med Healthcare GmbH Germany
参考成员国 - 产品名称
Sweden (SE)
51134
互认成员国 - 产品名称
Denmark (DK)
Netherlands (NL)
Carbidopa/Levodopa Fair-Med 12,5 mg/50 mg tabletten
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Norway (NO)
Carbidopa/Levodopa Fair-Med
许可日期
2016/01/21
最近更新日期
2024/01/30
药物ATC编码
N04BA02 levodopa and decarboxylase inhibitor
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1413_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1413_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1413_001_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1413_001_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase